Phase II trial of CC 223 in patients with cancer.
Latest Information Update: 17 Jan 2013
At a glance
- Drugs Onatasertib (Primary)
- Indications Cancer; Lymphoma; Solid tumours
- Focus Therapeutic Use
- 17 Jan 2013 New trial record
Latest Information Update: 17 Jan 2013